| NCT ID | NCT03592563 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Stroke, Ischemic |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2019-07-01 |
| Primary Completion | 2038-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2019-07-01 with a primary completion date of 2038-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to develop a large longitudinal cohort of individuals diagnosed with or at high risk for brain diseases (both neurological and psychiatric in nature), in order to identify risk factors that contribute to neurological and psychiatric diseases over time. The investigators seek to capture relevant information from medical records, electronically administered questionnaires and follow up phone-based interviews. The investigators expect to eventually have sufficient power from our dataset to examine risk factors for a variety of brain disorders, both individually and in aggregate. Our ultimate goal is to offer scientifically validated ways to preserve and promote brain health by working with our patients' needs and tracking their progress over time.
Eligibility Criteria
Inclusion Criteria: 1. Adult ≥ 18 years of age 2. Fulfilling criteria for membership in one of these three groups: * Red group: established diagnosis of one or more neurological and/or psychiatric conditions * Yellow group: high-risk to develop one or more neurological and/or psychiatric conditions 1. family history (first degree relative) one or more neurological and/or psychiatric conditions 2. examination, imaging or laboratory findings consistent with pre-symptomatic stages of one or more neurological and/or psychiatric disorders * Green group: not meeting criteria for Red or Yellow groups, but interested in longitudinal research on maintenance and/or improvement of brain health 3. Subject provides informed consent by signing and dating the written informed consent form 4. Subject is willing to answer health questionnaires and be followed longitudinally Exclusion Criteria: * None
Contact & Investigator
Thomas Wai Hong LEUNG, FRCP
PRINCIPAL INVESTIGATOR
Division of Neurology, The Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT03592563 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke, Ischemic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03592563 currently recruiting?
Yes, NCT03592563 is actively recruiting participants. Contact the research team at drtleung@cuhk.edu.hk for enrollment information.
Where is the NCT03592563 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong.
Who is sponsoring the NCT03592563 clinical trial?
NCT03592563 is sponsored by Chinese University of Hong Kong. The principal investigator is Thomas Wai Hong LEUNG, FRCP at Division of Neurology, The Chinese University of Hong Kong. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.